{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:42:36Z","timestamp":1792622556719,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11934-018-0818-8","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T06:37:06Z","timestamp":1528699026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Ureteral Stent Discomfort and Its Management"],"prefix":"10.1007","volume":"19","author":[{"given":"Katherine M.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Mucksavage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"818_CR1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0022-5347(17)57326-7","volume":"120","author":"RP Finney","year":"1978","unstructured":"Finney RP. Experience with new double J ureteral catheter stent. J Urol. 1978;120:678\u201381.","journal-title":"J Urol"},{"issue":"4","key":"818_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0090-4295(01)01644-2","volume":"59","author":"HB Joshi","year":"2002","unstructured":"Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG. Characterization of urinary symptoms in patients with ureteral stents. Urology. 2002;59(4):511\u20136.","journal-title":"Urology"},{"issue":"2","key":"818_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/089277901750134421","volume":"15","author":"HB Joshi","year":"2001","unstructured":"Joshi HB, Stainthorpe A, Keeley FX Jr, MacDonagh R, Timoney AG. Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis. J Endourol. 2001;15(2):151\u20134.","journal-title":"J Endourol"},{"issue":"3","key":"818_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/01.ju.0000049198.53424.1d","volume":"169","author":"HB Joshi","year":"2003","unstructured":"\u2022 Joshi HB, et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003;169(3):1060\u20134. The ureteral stent symptoms questionnaire (USSQ) described and validated in this paper is the only validated measure to study specifically stent-related symptoms. This measure is used by most groups investigating therapies to improve stent-related symptoms and is therefore important to be familiar with and understand.","journal-title":"J Urol"},{"issue":"4","key":"818_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4103\/0970-1591.57910","volume":"25","author":"R Miyaoka","year":"2009","unstructured":"Miyaoka R, Monga M. Ureteral stent discomfort: etiology and management. Indian Journal of Urology: IJU: Journal of the Urological Society of India. 2009;25(4):455\u201360. \n                      https:\/\/doi.org\/10.4103\/0970-1591.57910.","journal-title":"Indian Journal of Urology: IJU: Journal of the Urological Society of India"},{"key":"818_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00042307-200403000-00011","volume":"14","author":"BH Chew","year":"2004","unstructured":"Chew BH, Knudsen BH, Denstedt D. The use of stents in contemporary urology. Curr Opin Urol. 2004;14:111\u20135.","journal-title":"Curr Opin Urol"},{"key":"818_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.juro.2007.09.026","volume":"179","author":"G Haleblian","year":"2008","unstructured":"Haleblian G, Kijvikain K, de la Rosette J, Preminger G. Ureteral stenting and urinary stone management: a systematic review. J Urol. 2008;179:424\u201330.","journal-title":"J Urol"},{"issue":"2","key":"818_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/end.1993.7.137","volume":"7","author":"R Thomas","year":"1993","unstructured":"Thomas R. Indwelling ureteral stents: impact of material and shape on patient comfort. J Endourol. 1993;7(2):137\u201340.","journal-title":"J Endourol"},{"issue":"3","key":"818_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/01.ju.0000048980.33855.90","volume":"169","author":"HB Joshi","year":"2003","unstructured":"Joshi HB, Stainthorpe A, MacDonagh R, Keeley FX Jr, Timoney AG, Barry MJ. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol. 2003;169(3):1065\u20139; discussion\u20139.","journal-title":"J Urol"},{"issue":"6","key":"818_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1464-410X.1985.tb07021.x","volume":"57","author":"JW Ramsay","year":"1985","unstructured":"Ramsay JW, et al. The effects of double J stenting on unobstructed ureters. An experimental and clinical study. Br J Urol. 1985;57(6):630\u20134.","journal-title":"Br J Urol"},{"issue":"4","key":"818_CR11","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0022-5347(17)37976-4","volume":"146","author":"HA Mosli","year":"1991","unstructured":"Mosli HA, Farsi HMA, al-Zimaity MF, Saleh TR, al-Zamzami MM. Vesicoureteral reflux in patients with double pigtail stents. J Urol. 1991;146(4):966\u20139.","journal-title":"J Urol"},{"issue":"9","key":"818_CR12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1089\/end.2006.0252","volume":"21","author":"BH Chew","year":"2007","unstructured":"Chew BH, Knudsen BE, Nott L, Pautler SE, Razvi H, Amann J, et al. Pilot study of ureteral movement in stented patients: first step in understanding dynamic ureteral anatomy to improve stent comfort. J Endourol. 2007;21(9):1069\u201375.","journal-title":"J Endourol"},{"issue":"7","key":"818_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1089\/08927790152596352","volume":"15","author":"A Rane","year":"2001","unstructured":"Rane A, Saleemi A, Cahill D, Sriprasad S, Shrotri N, Tiptaft R. Have stent-related symptoms anything to do with placement technique? J Endourol. 2001;15(7):741\u20135.","journal-title":"J Endourol"},{"issue":"7","key":"818_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1089\/end.2007.9949","volume":"21","author":"AM Al-Kandari","year":"2007","unstructured":"Al-Kandari AM, et al. Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J Endourol. 2007;21(7):698\u2013702.","journal-title":"J Endourol"},{"issue":"7","key":"818_CR15","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1089\/end.2008.0037","volume":"22","author":"CH Ho","year":"2008","unstructured":"Ho CH, Chen SC, Chung SD, Lee YJ, Chen J, Yu HJ, et al. Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms. J Endourol. 2008;22(7):1427\u201331.","journal-title":"J Endourol"},{"issue":"1","key":"818_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/end.2006.20.33","volume":"20","author":"AR El-Nahas","year":"2006","unstructured":"El-Nahas AR, et al. Self-retaining ureteral stents: analysis of factors responsible for patients\u2019 discomfort. J Endourol. 2006;20(1):33\u20137.","journal-title":"J Endourol"},{"issue":"4","key":"818_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1464-410X.2010.09482.x","volume":"107","author":"G Giannarini","year":"2011","unstructured":"Giannarini G, Keeley Jr FX, Valent F, Manassero F, Mogorovich A, Autorino R, et al. Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated ureteric stent symptoms questionnaire. BJU Int. 2011;107(4):648\u201354.","journal-title":"BJU Int"},{"issue":"4","key":"818_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.eururo.2005.06.006","volume":"48","author":"R Damiano","year":"2005","unstructured":"Damiano R, Autorino R, de Sio M, Cantiello F, Quarto G, Perdon\u00e0 S, et al. Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol. 2005;48(4):673\u20138.","journal-title":"Eur Urol"},{"issue":"1","key":"818_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/end.1997.11.45","volume":"11","author":"JV Candela","year":"1997","unstructured":"Candela JV, Bellman GC. Ureteral stents: impact of diameter and composition on patient symptoms. J Endourol. 1997;11(1):45\u20137.","journal-title":"J Endourol"},{"issue":"2","key":"818_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/08927790360587342","volume":"17","author":"E Erturk","year":"2003","unstructured":"Erturk E, Sessions A, Joseph JV. Impact of ureteral stent diameter on symptoms and tolerability. J Endourol. 2003;17(2):59\u201362.","journal-title":"J Endourol"},{"issue":"2","key":"818_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00240-015-0810-4","volume":"44","author":"S Liu","year":"2016","unstructured":"Liu S, Yu Y, Gao Y, Yang X, Pang Z. Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study. Urolithiasis. 2016;44(2):185\u201390.","journal-title":"Urolithiasis"},{"issue":"4","key":"818_CR22","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.juro.2016.05.091","volume":"196","author":"D Assimos","year":"2016","unstructured":"Assimos D, et al. Surgical management of stones: American urological association\/endourological society guideline. J Urol. 2016;196(4):1161\u20139.","journal-title":"J Urol"},{"issue":"4","key":"818_CR23","first-page":"412","volume":"70","author":"M Taguchi","year":"2017","unstructured":"Taguchi M, Yoshida K, Sugi M, Matsuda T, Kinoshita H. A ureteral stent crossing the bladder midline leads to worse urinary symptoms. Central European Journal of Urology. 2017;70(4):412\u20137.","journal-title":"Central European Journal of Urology"},{"issue":"5","key":"818_CR24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4111\/kju.2015.56.5.370","volume":"56","author":"D Abt","year":"2015","unstructured":"Abt D, Mordasini L, Warzinek E, Schmid HP, Haile SR, Engeler DS, et al. Is intravesical stent position a predictor of associated morbidity? Korean Journal of Urology. 2015;56(5):370\u20138.","journal-title":"Korean Journal of Urology"},{"issue":"8","key":"818_CR25","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1089\/end.2005.19.990","volume":"19","author":"C Lee","year":"2005","unstructured":"Lee C, Kuskowski M, Premoli J, Skemp N, Monga M. Randomized evaluation of ureteral stents using validated symptom questionnaire. J Endourol. 2005;19(8):990\u20133.","journal-title":"J Endourol"},{"issue":"1","key":"818_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000475010","volume":"28","author":"GM Lennon","year":"1995","unstructured":"Lennon GM, Thornhill JA, Sweeney PA, Grainger R, McDermott TED, Butler MR. \u2018Firm\u2019 versus \u2018soft\u2019 double pigtail ureteric stents: a randomised blind comparative trial. Eur Urol. 1995;28(1):1\u20135.","journal-title":"Eur Urol"},{"issue":"3","key":"818_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/end.2014.0294","volume":"29","author":"HK Park","year":"2015","unstructured":"Park HK, Paick SH, Kim HG, Lho YS, Bae S. The impact of ureteral stent type on patient symptoms as determined by the ureteral stent symptom questionnaire: a prospective, randomized, controlled study. J Endourol. 2015;29(3):367\u201371.","journal-title":"J Endourol"},{"issue":"3","key":"818_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/21681805.2014.981205","volume":"49","author":"JN Lee","year":"2015","unstructured":"Lee JN, Kim BS. Comparison of efficacy and bladder irritation symptoms among three different ureteral stents: a double-blind, prospective, randomized controlled trial. Scandinavian Journal of Urology. 2015;49(3):237\u201341.","journal-title":"Scandinavian Journal of Urology"},{"issue":"6","key":"818_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4111\/icu.2017.58.6.440","volume":"58","author":"M Taguchi","year":"2017","unstructured":"Taguchi M, Inoue T, Muguruma K, Murota T, Kinoshita H, Matsuda T. Impact of loop-tail ureteral stents on ureteral stent-related symptoms immediately after ureteroscopic lithotripsy: comparison with pigtail ureteral stents. Investigative and clinical urology. 2017;58(6):440\u20136.","journal-title":"Investigative and clinical urology"},{"issue":"8","key":"818_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1089\/end.2004.18.723","volume":"18","author":"DT Beiko","year":"2004","unstructured":"Beiko DT, Watterson JD, Knudsen BE, Nott L, Pautler SE, Brock GB, et al. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. J Endourol. 2004;18(8):723\u201330.","journal-title":"J Endourol"},{"issue":"10","key":"818_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.5489\/cuaj.4408","volume":"11","author":"G Roberts","year":"2017","unstructured":"Roberts G, Leslie R, Robb S, Siemens DR, Beiko D. Intraureteral lidocaine for ureteral stent symptoms post-ureteroscopy: a randomized, phase 2, placebo-controlled trial. Canadian Urological Association Journal. 2017;11(10):326\u201330.","journal-title":"Canadian Urological Association Journal"},{"issue":"2","key":"818_CR32","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.juro.2009.10.021","volume":"183","author":"M Gupta","year":"2010","unstructured":"Gupta M, Patel T, Xavier K, Maruffo F, Lehman D, Walsh R, et al. Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction. J Urol. 2010;183(2):598\u2013602.","journal-title":"J Urol"},{"issue":"3","key":"818_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/end.2007.9847","volume":"22","author":"RL Sur","year":"2008","unstructured":"Sur RL, Haleblian GE, Cantor DA, Springhart WP, Albala DM, Preminger GM. Efficacy of intravesical ropivacaine injection on urinary symptoms following ureteral stenting: a randomized, controlled study. J Endourol. 2008;22(3):473\u20138.","journal-title":"J Endourol"},{"key":"818_CR34","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1464-410X.2011.10903.x","volume":"110","author":"CE Mendez-Probst","year":"2012","unstructured":"Mendez-Probst CE, Goneau LW, MacDonald KW, Nott L, Seney S, Elwood CN, et al. The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospectiverandomized trial. BJU Int. 2012;110:749\u201354.","journal-title":"BJU Int"},{"key":"818_CR35","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.juro.2009.11.035","volume":"183","author":"AE Krambeck","year":"2010","unstructured":"Krambeck AE, Walsh RS, Denstedt JD, Preminger GM, Li J, Evans JC, et al. A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol. 2010;183:1037\u201342.","journal-title":"J Urol"},{"key":"818_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.urology.2016.07.035","volume":"100","author":"FC Lee","year":"2017","unstructured":"Lee FC, Holt SK, Hsi RS, Haynes BM, Harper JD. Preoperative belladonna and opium suppository for ureteral stent pain: a randomized, double-blinded, placebo-controlled study. Urology. 2017;100:27\u201332.","journal-title":"Urology"},{"issue":"7","key":"818_CR37","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1089\/end.2016.0129","volume":"30","author":"C Koprowski","year":"2016","unstructured":"\u2022\u2022 Koprowski C, Kim C, Modi PK, Elsamra SE. Ureteral stent-associated pain: a review. J Endourol. 2016;30(7):744\u201353. A good, recent review of factors associated with stent-related pain and the proposed mechanisms of stent-related symptoms.","journal-title":"J Endourol"},{"issue":"11","key":"818_CR38","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/j.1464-410X.2011.10170.x","volume":"108","author":"AD Lamb","year":"2011","unstructured":"Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ. Meta-analysis showing the beneficial effect of alpha-blockers on ureteric stent discomfort. BJU Int. 2011;108(11):1894\u2013902.","journal-title":"BJU Int"},{"issue":"1","key":"818_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12894-015-0050-5","volume":"15","author":"JK Kwon","year":"2015","unstructured":"Kwon JK, Cho KS, Oh CK, Kang DH, Lee H, Ham WS, et al. The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo. BMC Urol. 2015;15(1):55.","journal-title":"BMC Urol"},{"key":"818_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00240-013-0554-y","volume":"41","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Huang KH, Yang HJ, Chang HC, Chen J, Yang TK. Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy. Urolithiasis. 2013;41:247\u201352.","journal-title":"Urolithiasis"},{"issue":"8","key":"818_CR41","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00345-016-1988-y","volume":"35","author":"MH Abdelhamid","year":"2017","unstructured":"Abdelhamid MH, Zayed AS, Ghoneima WE, Elmarakbi AA, el Sheemy MS, Aref A, et al. Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospium chloride in the relief of double-J stent-related symptoms. World J Urol. 2017;35(8):1261\u20138.","journal-title":"World J Urol"},{"issue":"7","key":"818_CR42","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00345-015-1704-3","volume":"34","author":"AR El-nahas","year":"2016","unstructured":"El-nahas AR, Tharwat M, Elsaadany M, Mosbah A, Gaballah MA. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms. World J Urol. 2016;34(7):963\u20138.","journal-title":"World J Urol"},{"key":"818_CR43","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1089\/end.2014.0715","volume":"29","author":"L Zhou","year":"2015","unstructured":"\u2022\u2022 Zhou L, Cai X, Li H, Wang KJ. Effects of \u03b1-blockers, antimuscarinics, or combination therapy in relieving ureteral stent-related symptoms: a meta-analysis. J Endourol. 2015;29:650. This meta-analysis found that both anticholinergics and alpha-blockers decrease stent discomfort with the combination of both types of medications being superior to monotherapy.\u20136.","journal-title":"J Endourol"},{"key":"818_CR44","doi-asserted-by":"crossref","unstructured":"Zhang YM, Chu P, Wang WJ. PRISMA-combined \u03b1-blockers and antimuscarinics for ureteral stent-related symptoms: a meta-analysis. Medicine. 2017;96(7)","DOI":"10.1097\/MD.0000000000006098"},{"issue":"1","key":"818_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000449390","volume":"99","author":"H Yan","year":"2017","unstructured":"Yan H, Wang Y, Sun R, Cui Y. The efficacy of antimuscarinics alone or in combination with alpha-blockers for the treatment of ureteral stent-related symptoms: a systematic review and meta-analysis. Urol Int. 2017;99(1):6\u201313.","journal-title":"Urol Int"},{"issue":"5","key":"818_CR46","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.urology.2007.11.004","volume":"71","author":"RD Norris","year":"2008","unstructured":"Norris RD, Sur RL, Springhart WP, Marguet CG, Mathias BJ, Pietrow PK, et al. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology. 2008;71(5):792\u20135.","journal-title":"Urology"},{"key":"818_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1464-410X.2012.11214.x","volume":"111","author":"NN Tadros","year":"2013","unstructured":"Tadros NN, Bland L, Legg E, Olyaei A, Conlin MJ. A single dose of a non-steroidal anti-inflammatory drug (NSAID) prevents severe pain after ureteric stent removal: a prospective, randomised, double-blind, placebo-controlled trial. BJU Int. 2013;111:101\u20135.","journal-title":"BJU Int"},{"issue":"6","key":"818_CR48","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s11255-017-1561-7","volume":"49","author":"M Ragab","year":"2017","unstructured":"Ragab M, Soliman MG, Tawfik A, Abdel Raheem A, el-Tatawy H, Abo Farha M, et al. The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial. Int Urol Nephrol. 2017;49(6):961\u20136.","journal-title":"Int Urol Nephrol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-018-0818-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-018-0818-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-018-0818-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T23:09:08Z","timestamp":1560208148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-018-0818-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1007\/s11934-018-0818-8","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"assertion":[{"value":"11 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Katherine M. Fischer and Michael Louie each declare no potential conflicts of interest.Phillip Mucksavage is a section editor for Current Urology Reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"64"}}